Estrogen, natriuretic peptides and the renin-angiotensin system

Cardiovascular Research

Volumn 41, Issue 3, 1999, Pages 524-531

  Kuroski De Bold, Mercedes L ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Hormones; Hypertension; Natriuretic peptide; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; HEART RECEPTOR; RENIN; TESTOSTERONE;

ESTROGEN ACTIVITY; GENE EXPRESSION; HEART PROTECTION; HEMODYNAMICS; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR DISEASES; ESTROGENS; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; RATS; RECEPTORS, ESTROGEN; RENIN-ANGIOTENSIN SYSTEM; TESTOSTERONE;

EID: 0033066487     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00324-1     Document Type: Review

References (102)

1. Hanes D.S., Weir M.R., Sowers J.R. Gender considerations in hypertension pathophysiology and treatment. Am J Med. 101(Suppl. 3A):1996;10S-21S.
2. Pelzer T., Shamim A., Neyses L. Estrogen effects in the heart. Mol Cell Biochem. 160(161):1996;307-313.
3. Schenck-Gustafsson K. Risk factors for cardiovascular disease in women: assessment and management. Eur Heart J. 17:1996;2-8.
4. Pines A., Mijatovic V., van der Mooren M.J., Kenemans P. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynecol Reprod Biol. 71:1997;193-197.
5. The writing group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc 1995;273:199-208.
6. Hong M.K., Romm P.A., Reagan K., Green C.E., Rackley C.E. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol. 69:1992;176-178.
7. Rozenberg S., Liebens I., Vandromme J., Hotimsky A., Van Rijsselberge M. Cardiovascular protection by estrogen: a hemodynamic mechanism? Int J Fertil. 39(Suppl 1):1994;36-42.
8. Lieberman E.H., Gerhard M.D., Uehata A.et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
9. Griendling K.K., Murphy T.J., Alexander R.W. Molecular biology of the renin-angiotensin system. Circulation. 87(6):1993;1816-1828.
10. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V.et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
11. Linz W., Schölkens B.A., Lindpaintner K., Ganten D. Cardiac renin-angiotensin system. Am J Hypertens. 2:1989;307-310.
12. Lee M.A.E., Paul M., Böhm M., Ganten D. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin system. Am J Cardiol. 70:1992;12C-19C.
13. Lee M.A., Bohm M., Paul M., Ganten D. Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation. 87(Suppl.5):1993;V7-V13.
14. Krieger J.E., Dzau V.J. Molecular biology of hypertension. Hypertension. 18:1991;13-17.
15. Ruzicka M., Leenen F.H. Update on local cardiac renin-angiotensin system. Curr Opin Cardiol. 12:1997;347-353.
16. Hayashi H., Shibata S. Electric property of cardiac cell membrane of spontaneously hypertensive rat. Eur J Pharmacol. 27:1974;255-259.
17. Dostal D.E., Baker K.M. Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts. Trends Cardiovasc Med. 3:1993;67-74.
18. Ganten U., Schröder G., Witt M.et al. Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J Hypertens. 7:1989;721-726.
19. Chen Y.F., Naftilan A.J., Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension. 19:1992;456-463.
20. Bachmann J., Wagner J., Haufe C.et al. Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats after ovariectomy. J Hypertens. 11:1993;S226-S227.
21. Nickenig G., Baumer A., Grohe C.et al. Estrogen modulates at receptor gene expression in vitro and in vivo. Circulation. 97:1998;2197-2201.
22. Gordon M.S., Chin W.W., Shupnik M.A. Regulation of angiotensinogen gene expression by estrogen. J Hypertens. 10:1992;361-366.
23. Wheeler M.A., Pontari M., Dokita S.et al. Age-dependent changes in particulate and soluble guanylyl cyclase activities in urinary tract smooth muscle. Mol Cell Biochem. 169:1997;115-124.
24. von Harsdorf R., Edwards J.G., Shen Y.T.et al. Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. J Clin Invest. 100:1997;1294-1304.
25. Rosenzweig A., Halazonetis T.D., Seidman J.G., Seidman C.E. Proximal regulatory domains of rat atrial natriuretic factor gene. Circulation. 84:1991;1256-1265.
26. Brosnihan K.B., Li P., Ganten D., Ferrario C.M. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol Regul Integr Comp Physiol. 273(6 Pt.2):1997;R1908-R1915.
27. Brosnihan K.B., Weddle D., Anthony M.S.et al. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens. 15:1997;719-726.
28. Mercuro G., Zoncu S., Pilia I.et al. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am J Cardiol. 80:1977;652-655.
29. Foidart J.-M. Use of transdermal oestradiol (estraderm tts) in hypertensive postmenopausal women. Biol J Clin Prac Suppl. 86:1996;14-16.
30. Barrett-Connor E., Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. Br Med J. 311:1995;1193-1196.
31. Rossouw J.E. Estrogens for prevention of coronary heart disease. Circulation. 94:1996;2982-2985.
32. Hassager C., Riis B.J., Strom V., Guyene T.T., Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation. 76(4):1987;753-758.
33. De Lignieres B., Basdevant A., Thomas G.et al. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab. 62(3):1986;536-541.
34. Proudler A.J., Ahmed A.I.H., Crook D.et al. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet. 346:1995;89-90.
35. Scarabin P.Y., Billaud E., Plu-Bureau G., Agher R. HRT and ACE activity in postmenopausal women. Lancet. 347(8994):1996;122.
36. Oelkers W.K.H. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids. 61:1996;166-171.
37. Derkx F.H., Steunkel C., Schalekamp M.P.et al. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab. 63(4):1986;1008-1015.
38. Flynn T.G. The elucidation of the structure of atrial natriuretic factor, a new peptide hormone. Can J Physiol Pharmacol. 65:1987;2013-2020.
39. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev. 44:1992;479-602.
40. Bonow R.O. New insights into the cardiac natriuretic peptides [editorial; comment]. Circulation. 93:1996;1946-1950.
41. Wilkins M.R., Redondo J., Brown L.A. The natriuretic-peptide family. Lancet. 349:1997;1307-1310.
42. Lang R.E., Unger T., Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens. 5:1987;255-271.
43. Huang H.M., Acuff C.G., Steinhelper M.E. Isolation, mapping, and regulated expression of the gene encoding mouse C-type natriuretic peptide. Am J Physiol. 271:1996;H1565-H1575.
44. Davidson N.C., Struthers A.D. Brain natriuretic peptide [editorial, review]. J Hypertens. 12:1994;329-336.
45. Yoshibayashi M., Saito Y., Nakao K. Brain natriuretic peptide versus atrial natriuretic peptide - physiological and pathophysiological significance in children and adults: A review. Eur J Endocrinol. 135:1996;265-268.
46. Chen Y.F. Sexual dimorphism of hypertension. Curr Opin Nephrol Hypertens. 6:1996;181-185.
47. Hong M., Yan Q., Tao B.et al. Estradiol, progesterone and testosterone exposures affect the atrial natriuretic peptide gene expression in vivo in rats. Biol Chem Hoppe-Seyler. 373:1992;213-218.
48. Hwu C.M., Tsai S.C., Lau C.P.et al. Increased concentrations of atrial and plasma atrial natriuretic peptide in castrated male rats. Life Sci. 52:1993;205-212.
49. Matsubara H., Hirata Y., Yoshimi H.et al. Effects of steroid and thyroid hormones on synthesis of atrial natriuretic peptide by cultured atrial myocytes of rat. Biochem Biophys Res Commun. 145:1987;336-343.
50. Matsubara H., Hirata Y., Yoshimi H.et al. Ventricular myocytes from neonatal rats are more responsive to dexamethasone than atrial myocytes in synthesis of atrial natriuretic peptide. Biochem Biophys Res Commun. 148:1987;1030-1038.
51. Gardner D.G., Gertz B.J., Deschepper C.F., Kim D.Y. Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro. J Clin Invest. 82:1988;1275-1281.
52. Li Q., Gardner D.G. Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3. J Biol Chem. 269:1994;4934-4939.
53. Navaratnam V., Woodward J.M., Skepper J.N. Specific heart granules and natriuretic peptide in the developing myocardium of fetal and neonatal rats and hamsters. J Anat. 163:1989;261-273.
54. Brenner C.A., Tam A.W., Nelson P.A.et al. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques. 7:1989;1096-1103.
55. Kuroski de Bold ML, de Bold AJ. Gender-related differences in natriuretic peptide gene expression in hypertension. J Mol Cell Cardiol 1996;28:T46 (Abstract).
56. Kuroski de Bold M.L. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during post-natal development. Hypertension. 11:1998;1006-1018.
57. Clark B.A., Elahi D., Epstein F.H. The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide. J Clin Endocrinol Metab. 70:1990;349-352.
58. Van Hooft I.M., Grobbee D.E., Hofman A., Schiffers P., de Pont J.J. Atrial natriuretic factor and sodium intake in offspring of hypertensive and normotensive parents [letter]. N Engl J Med. 320:1989;867-868.
59. Davidson B.J., Rea C.D., Valenzuela G.J. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome. Fertil Steril. 50:1988;743-746.
60. Bisson D.L., Dunster G.D., O'Hare J.P., Hampton D., Penney M.D. Renal sodium retention does not occur during the luteal phase of the menstrual cycle in normal women. Br J Obstet Gynaecol. 99:1992;247-252.
61. Sealey J.E., Itskovitz-Eldor J., Rubattu S.et al. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 79(1):1994;258-264.
62. Yeko T.R., Rao P.S., Parsons A.K.et al. Atrial natriuretic peptide, oestradiol and progesterone in women undergoing spontaneous and gonadotrophin-stimulated ovulatory cycles. Hum Reprod. 10(11):1995;2872-2874.
63. Jensen L.K., Svanegaard J., Husby H. Atrial natriuretic peptide during the menstrual cycle. Am J Obstet Gynecol. 161:1989;951-952.
64. Marttila M., Vuolteenaho O., Ganten D., Nakao K., Ruskoaho H. Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat. Hypertension. 28:1996;995-1004.
65. Ogawa T., Linz W., Stevenson M.et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation. 93:1996;2059-2067.
66. Linz W., Schölkens B.A., Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens. 11:1989;1325-1350.
67. Wahlander H., Sohtell M., Wickman A., Nilsson A., Friberg P. Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 27:1996;327-334.
68. Gottshall K.R., Hunter J.J., Tanaka N.et al. Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. Proc Natl Acad Sci USA. 94:1997;4710-4715.
69. Ohta K., Kim S., Iwao H. Role of angiotensin-converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development. Hypertension. 28:1996;627-634.
70. Makino N., Sugano M., Otsuka S., Hata T. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension. 30:1997;796-802.
71. Ohta K., Kim S., Wanibuchi H., Ganten D., Iwao H. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats. Circulation. 94:1996;785-791.
72. Kawaguchi H., Sawa H., Yasuda H. Effect of atrial naturiuretic factor on angiotensin converting enzyme. J Hypertens. 8(8):1990;749-753.
73. Morgan K., Wharton J., Webb J.C.et al. Co-expression of renin-angiotensin system component genes in human atrial tissue. J Hypertens [Suppl]. 12:1994;S11-S19.
74. Zhang X., Dostal D.E., Reiss K.et al. Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. Am J Physiol. 269(5 Pt 2):1995;H1791-H1802.
75. Mazzolai L., Nussberger J., Aubert J.F.et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension. 31(6):1998;1324-1330.
76. Danser A.H.J., Schalekamp A.D.H. Is there an internal cardiac renin-angiotensin system? Heart. 76:1996;28-32.
77. Collins P., Beale C.M., Rosano G.M.C. Oestrogen as a calcium channel blocker. Eur Heart J. 17(Suppl D):1996;27-31.
78. Hayashi T., Yamada K., Esaki T.et al. Physiological concentrations of 17β-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. J Cardiovasc Pharmacol. 31(2):1998;292-298.
79. Kleinert H., Wallerath T., Euchenhofer E.et al. Estrogens increase transcription of the human endothelial NO synthase gene. Hypertension. 31:1998;582-588.
80. Freay A.D., Curtis S.W., Korach K.S., Rubanyi G.M. Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta. Circ Res. 81:1997;242-248.
81. Chen S.J., Li H., Durand J., Oparil S., Chen Y.F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 93:1996;577-584.
82. Iams S.G., Wexler B.C. Retardation in the development of spontaneous hypertension in SH rats by gonadectomy. J Lab Clin Med. 90(6):1977;997-1003.
83. Masubuchi Y., Kumai T., Ucmatsu A., Komoriyama K., Hirai M. Gonadectomy-induced reduction of blood pressure in adult spontaneously hypertensive rats. Acta Endocrinol. 11:1982;154-160.
84. Nishikimi T., Saito Y., Kitamura K.et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 26:1995;1424-1431.
85. Schaible T.F., Malhotra A., Ciambrone G., Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res. 54(1):1984;38-49.
86. Porter C.B., Gumprecht E., Geer P.G., Goetz K.L. Plasma atrial peptide concentration during acute changes in cardiac filling pressure induced by a contrast agent. Clin Cardiol. 10:1987;289-292.
87. Crofton J.T., Share L. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension. 29:1997;494-499.
88. Chen Y.F., Meng Q.C. Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci. 48(1):1991;85-96.
89. Kumai T., Tanaka M., Watanabe M., Nakura H., Kobayashi S. Influence of androgen on tyrosine hydroxylase mRNA in adrenal medulla of spontaneously hypertensive rats. Hypertension. 26:1995;208-212.
90. Scheuer J., Malhotra A., Schaible T.F., Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res. 61:1987;12-19.
91. Reckelhoff J.F., Zhang H., Granger J.P. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension. 31(Part 2):1998;435-439.
92. Grohé C., Kahlert S., Löbbert K.et al. Modulation of hypertensive heart disease by estrogen. Steroids. 61:1996;201-204.
93. Perrot-Applanat M. Estrogen receptors in the cardiovascular system. Steroids. 61:1996;212-215.
94. Back H., Forssmann W.G., Stumpf W.E. Atrial myoendocrine cells (cardiodilatin/atrial natriuretic polypeptide-containing myocardiocytes) are target cells for estradiol. Cell Tissue Res. 255:1989;673-674.
95. Stumpf W.E. Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, gluco- and mineralocorticoids, and soltriol [vitamin D] on central nervous regulatory and peripheral tissues. Experientia. 46:1990;13-25.
96. Lin A.L., Schultz J.J., Brenner R.M., Shain S.A. Sexual dimorphism characterizes baboon myocardial androgen receptors but not myocardial estrogen and progesterone receptors. J Steroid Biochem Mol Biol. 37(1):1990;85-95.
97. Grohé C., Kahlert S., Löbbert K., Vetter H. Expression of oestrogen receptor α and β in rat heart: role of local oestrogen synthesis. J Endocrinol. 156:1998;R1-R7.
98. Kimmelstiel C.D., Konstam M.A. Heart failure in women. Cardiology. 86:1995;304-309.
99. de Simone G., Devereux R.B., Roman M.J.et al. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol. 68:1991;1074-1078.
100. Villablanca A.C. Coronary heart disease in women. Gender differences and effects of menopause. Postgrad Med. 100(3):1996;191-202.
101. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? Circulation. 95:1997;252-264.
102. Cacciabaudo JM, August P. Female sex hormones and cardiovascular disease: implications for therapy. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1995:2391-2406.